Matthew Hawryluk serves as Executive at Gritstone bio, Inc., where they oversee executive responsibilities. Since joining the company, Matthew Hawryluk has executed 13 insider transactions totaling $6.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 9, 2025 involved receiving (via award) 64,680 shares valued at $0.
Matthew Hawryluk currently holds 74,168 shares of Gritstone bio, Inc. (GRTS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Hawryluk has been a net seller of GRTS stock. They have purchased $0 and sold $6.9K worth of shares.
Matthew Hawryluk's most recent insider trade was on Sep 9, 2025, when they sold 64,680 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.75 |
| Discretionary |
| May 15, 2024 | GRTS | $0 | Award | 19,149 | $N/A | Discretionary |
| Apr 5, 2024 | POAI | $0 | Award | 2,368 | $N/A | Discretionary |
| Feb 1, 2024 | GRTS | $0 | Award | 35,000 | $N/A | Discretionary |
| Oct 2, 2023 | POAI | $0 | Award | 1,875 | $N/A | Discretionary |
| Jul 3, 2023 | POAI | $0 | Award | 2,675 | $N/A | Discretionary |
| Apr 3, 2023 | POAI | $0 | Award | 18,360 | $N/A | Discretionary |
| Feb 2, 2023 | GRTS | $0 | Award | 191,771 | $N/A | Discretionary |
| Jan 3, 2023 | POAI | $0 | Award | 19,570 | $N/A | Discretionary |
| Dec 1, 2022 | POAI | $0 | Award | 13,762 | $N/A | Discretionary |
| Jan 31, 2022 | GRTS | $0 | Award | 21,612 | $N/A | Discretionary |
| Jan 7, 2021 | GRTS | $0 | Award | 19,600 | $N/A | Discretionary |